|Articles|March 15, 2018
- BioPharm International-03-15-2018
- Volume 2018 eBook
- Issue 1
Outsourcing: Does Focus Pay Off?
Author(s)Agnes Shanley
Research suggests that working with a single contract partner can reduce development time and improve economics.
Advertisement
Competitive pressures have led to explosive growth in demand for research and development (R&D) outsourcing, especially as smaller biopharma and pharmaceutical companies play a more prominent role in drug development. Pharmaceutical manufacturers, especially small- to mid-sized companies, are discovering that partnering more closely with one diversified contract company can reduce development time and cost.
View other articles in
Article Details
BioPharm International
eBook: Outsourcing Resources 2018
March 2018
Pages: 4–6
Citation
When referring to this article, please cite it as A. Shanley, “Outsourcing: Does Focus Pay Off?," BioPharm International Outsourcing Resources eBook (March 2018).
Articles in this issue
over 7 years ago
Quality Oversight During Sterile Filling Operationsover 7 years ago
Good Quality Agreements Support Compliance with CGMPover 7 years ago
Gaining Analytical Insight in the Development of Biologicsover 7 years ago
Contract Services Investment Updateover 7 years ago
Process Validation in Biologics Developmentover 7 years ago
Bigger is Better in Samsung's Approach to Biomanufacturingover 7 years ago
Choosing an Analytical Partner in Early Drug Developmentover 7 years ago
Avoiding Complete Response LettersNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
